Literature DB >> 25548290

p38 MAPK down-regulates fibulin 3 expression through methylation of gene regulatory sequences: role in migration and invasion.

María Arechederra1, Neibla Priego1, Ana Vázquez-Carballo1, Celia Sequera1, Álvaro Gutiérrez-Uzquiza1, María Isabel Cerezo-Guisado2, Sara Ortiz-Rivero3, Cesáreo Roncero1, Ana Cuenda2, Carmen Guerrero4, Almudena Porras5.   

Abstract

p38 MAPKs regulate migration and invasion. However, the mechanisms involved are only partially known. We had previously identified fibulin 3, which plays a role in migration, invasion, and tumorigenesis, as a gene regulated by p38α. We have characterized in detail how p38 MAPK regulates fibulin 3 expression and its role. We describe here for the first time that p38α, p38γ, and p38δ down-regulate fibulin 3 expression. p38α has a stronger effect, and it does so through hypermethylation of CpG sites in the regulatory sequences of the gene. This would be mediated by the DNA methylase, DNMT3A, which is down-regulated in cells lacking p38α, but once re-introduced represses Fibulin 3 expression. p38α through HuR stabilizes dnmt3a mRNA leading to an increase in DNMT3A protein levels. Moreover, by knocking-down fibulin 3, we have found that Fibulin 3 inhibits migration and invasion in MEFs by mechanisms involving p38α/β inhibition. Hence, p38α pro-migratory/invasive effect might be, at least in part, mediated by fibulin 3 down-regulation in MEFs. In contrast, in HCT116 cells, Fibulin 3 promotes migration and invasion through a mechanism dependent on p38α and/or p38β activation. Furthermore, Fibulin 3 promotes in vitro and in vivo tumor growth of HCT116 cells through a mechanism dependent on p38α, which surprisingly acts as a potent inducer of tumor growth. At the same time, p38α limits fibulin 3 expression, which might represent a negative feed-back loop.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cancer biology; cell signaling; fibulin 3; invasion; migration; p38 MAPK

Mesh:

Substances:

Year:  2014        PMID: 25548290      PMCID: PMC4326844          DOI: 10.1074/jbc.M114.582239

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development.

Authors:  R H Adams; A Porras; G Alonso; M Jones; K Vintersten; S Panelli; A Valladares; L Perez; R Klein; A R Nebreda
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

Review 2.  Fibulins and cancer: friend or foe?

Authors:  William M Gallagher; Caroline A Currid; Linda C Whelan
Journal:  Trends Mol Med       Date:  2005-07       Impact factor: 11.951

3.  The p38 transduction pathway in prostatic neoplasia.

Authors:  M Ricote; I García-Tuñón; F Bethencourt; B Fraile; P Onsurbe; R Paniagua; M Royuela
Journal:  J Pathol       Date:  2006-02       Impact factor: 7.996

Review 4.  Map kinase signaling pathways and hematologic malignancies.

Authors:  Leonidas C Platanias
Journal:  Blood       Date:  2003-03-06       Impact factor: 22.113

5.  p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis.

Authors:  Ignacio Dolado; Aneta Swat; Nuria Ajenjo; Gabriella De Vita; Ana Cuadrado; Angel R Nebreda
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

6.  Transcriptional regulation and expression of the dominant drusen gene FBLN3 (EFEMP1) in mammalian retina.

Authors:  James Blackburn; Emma E Tarttelin; Cheryl Y Gregory-Evans; Mariya Moosajee; Kevin Gregory-Evans
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

7.  Pro-oncogenic role of alternative p38 mitogen-activated protein kinases p38γ and p38δ, linking inflammation and cancer in colitis-associated colon cancer.

Authors:  Paloma Del Reino; Dayanira Alsina-Beauchamp; Alejandra Escós; Ma Isabel Cerezo-Guisado; Ana Risco; Noelia Aparicio; Rafal Zur; Marian Fernandez-Estévez; Elena Collantes; Jose Montans; Ana Cuenda
Journal:  Cancer Res       Date:  2014-09-12       Impact factor: 12.701

8.  P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli.

Authors:  Almudena Porras; Susana Zuluaga; Emma Black; Amparo Valladares; Alberto M Alvarez; Concetta Ambrosino; Manuel Benito; Angel R Nebreda
Journal:  Mol Biol Cell       Date:  2003-11-14       Impact factor: 4.138

9.  CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway.

Authors:  Simon Rousseau; Ignacio Dolado; Victoria Beardmore; Natalia Shpiro; Rudolfo Marquez; Angel R Nebreda; J Simon C Arthur; Lauren M Case; Marc Tessier-Lavigne; Matthias Gaestel; Ana Cuenda; Philip Cohen
Journal:  Cell Signal       Date:  2006-03-06       Impact factor: 4.315

10.  The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation.

Authors:  Christopher Tiedje; Natalia Ronkina; Mohammad Tehrani; Sonam Dhamija; Kathrin Laass; Helmut Holtmann; Alexey Kotlyarov; Matthias Gaestel
Journal:  PLoS Genet       Date:  2012-09-27       Impact factor: 5.917

View more
  16 in total

1.  Fibulin-3 promotes muscle-invasive bladder cancer.

Authors:  A L Han; B A Veeneman; L El-Sawy; K C Day; M L Day; S A Tomlins; E T Keller
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

2.  Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.

Authors:  Anan H Said; Shien Hu; Ameer Abutaleb; Tonya Watkins; Kunrong Cheng; Ahmed Chahdi; Panjamurthy Kuppusamy; Neeraj Saxena; Guofeng Xie; Jean-Pierre Raufman
Journal:  Biochem J       Date:  2017-02-20       Impact factor: 3.857

3.  EFEMP1 promotes ovarian cancer cell growth, invasion and metastasis via activated the AKT pathway.

Authors:  Xiuxiu Yin; Shuang Fang; Mei Wang; Qiang Wang; Rui Fang; Jie Chen
Journal:  Oncotarget       Date:  2016-07-26

4.  Role of p38alpha/beta MAP Kinase in Cell Susceptibility to Clostridium sordellii Lethal Toxin and Clostridium difficile Toxin B.

Authors:  Ilona Schelle; Janina Bruening; Mareike Buetepage; Harald Genth
Journal:  Toxins (Basel)       Date:  2016-12-22       Impact factor: 4.546

5.  Zebularine Promotes Hepatic Differentiation of Rabbit Bone Marrow Mesenchymal Stem Cells by Interfering with p38 MAPK Signaling.

Authors:  Yong-Heng Luo; Juan Chen; En-Hua Xiao; Qiu-Yun Li; Yong-Mei Luo
Journal:  Stem Cells Int       Date:  2018-10-10       Impact factor: 5.443

Review 6.  Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells.

Authors:  Jingnan Xu; Zhuo Song; Qiujun Guo; Jie Li
Journal:  Biomed Res Int       Date:  2016-03-02       Impact factor: 3.411

7.  C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms.

Authors:  Neibla Priego; María Arechederra; Celia Sequera; Paloma Bragado; Ana Vázquez-Carballo; Álvaro Gutiérrez-Uzquiza; Víctor Martín-Granado; Juan José Ventura; Marcelo G Kazanietz; Carmen Guerrero; Almudena Porras
Journal:  Oncotarget       Date:  2016-07-19

8.  The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion.

Authors:  Michelle M Noonan; Magdalena Dragan; Michael M Mehta; David A Hess; Muriel Brackstone; Alan B Tuck; Navin Viswakarma; Ajay Rana; Andy V Babwah; Frederic E Wondisford; Moshmi Bhattacharya
Journal:  Oncotarget       Date:  2018-07-10

9.  Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer.

Authors:  Jonathan W Goldman; Lee S Rosen; Anthony W Tolcher; Kyriakos Papadopoulos; Muralidhar Beeram; Peipei Shi; Celine Pitou; Robert Bell; Palaniappan Kulanthaivel; Xuekui Zhang; Aaron Fink; Edward M Chan; Ashwin Shahir; Daphne Farrington; Amita Patnaik
Journal:  Invest New Drugs       Date:  2017-12-01       Impact factor: 3.850

Review 10.  Novel Associations Within the Tumor Microenvironment: Fibulins Meet ADAMTSs.

Authors:  Tania Fontanil; Yamina Mohamedi; Teresa Cobo; Santiago Cal; Álvaro J Obaya
Journal:  Front Oncol       Date:  2019-08-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.